Can we cure refractory Hodgkin’s lymphoma with transplantation?-Reference-Cited by-同舟云学术

Can we cure refractory Hodgkin’s lymphoma with transplantation?

Published:2020-07-07 Issue:1 Volume:56 Page:278-281
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ciurea Stefan O.^ORCID,Kongtim Piyanuch,Srour Samer,Saini Neeraj,Im Jin,Ramdial Jeremy,Khouri Issa,Anderlini Paolo,Popat Uday,Hosing Chitra,Champlin Richard E.^ORCID,Lee Hun J.,Fayad Luis E.,Hagemeister Fredrick B.,Bica Ana M.,Lipan Lavinia,Craciun Oana,Jercan Cristina G.,Tanase Alina,Colita Anca

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0989-z.pdf

Reference12 articles.

1. Martinez C, Gayoso J, Canals C, Finel H, Peggs K, Dominietto A, et al. Post-transplantation cyclophosphamide-based haploidentical transplantation as alternative to matched sibling or unrelated donor transplantation for Hodgkin lymphoma: a registry study of the lymphoma working party of the European society for blood and marrow transplantation. J Clin Oncol: Off J Am Soc Clin Oncol. 2017;35:3425–32. https://doi.org/10.1200/jco.2017.72.6869.

2. Lacerda MP, Arrais Rodrigues C, Pereira AD, Novis Y, Fonseca M, Silva RL, et al. Human leukocyte antigen-haploidentical transplantation for relapsed/refractory Hodgkin lymphoma: a multicenter analysis. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2017;23:705–7. https://doi.org/10.1016/j.bbmt.2017.01.079.

3. Gauthier J, Castagna L, Garnier F, Guillaume T, Socie G, Maury S, et al. Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone marrow Transplant. 2017;52:689–96. https://doi.org/10.1038/bmt.2016.349.

4. Castagna L, Bramanti S, Devillier R, Sarina B, Crocchiolo R, Furst S, et al. Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma. Bone marrow Transplant. 2017;52:797 https://doi.org/10.1038/bmt.2017.26.

5. Marani C, Raiola AM, Morbelli S, Dominietto A, Ferrarazzo G, Avenoso D, et al. Haploidentical transplants with post-transplant cyclophosphamide for relapsed or refractory Hodgkin lymphoma: the role of comorbidity index and pretransplant positron emission tomography. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2018;24:2501–8. https://doi.org/10.1016/j.bbmt.2018.07.025.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes;Journal of Personalized Medicine;2022-01-18

2. Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls;Journal of Clinical Medicine;2020-11-07